Evidence into Action
We are generating evidence about the use cases for oxygen concentrators and other small-scale solutions delivered through oxygen-as-a-service models, in order to support decision making on oxygen provision in low-resource settings both nationally and globally.
Generating evidence about the use cases for concentrators and services-based models across different facility archetypes
Our Product Innovation and Oxygen-as-a-Service portfolios will generate new learning about what works in different types of facilities and contexts. Our evidence framework guides us on the evidence to collect which will help us build the use cases for oxygen concentrators and Oxygen-as-a-Service.
We will collect evidence on:
patient access to oxygen in pilot facilities
the added-value and availability of products, and services
financing and the demand for products and services
the local and national enabling environments surrounding the purchase and implementation of new oxygen concentrators and oxygen-as-a-service models
We hope to create accessible, evidence based recommendations that support global, national and local decision makers as they fund, procure, and implement concentrators (and other small-scale solutions) delivered through services-based models.
Our aim is for our practical real-world insights to stimulate the ongoing collective conversation about oxygen delivery at lower-levels of health. We exist to contribute to, not duplicate existing work in this space. We hope that our evidence will complement research that is already underway, identify new evidence gaps, and support the building of shared understanding of what works, where, and when.
Read more of our underlying thinking and look at our indicators in the evidence framework here.
We know that evidence alone will not make an impact, if it’s not in the hands of the right people. In order to unlock scale for our Oxygen-as-a-Service and Product Innovation portfolios, we believe that national and global policy makers will need to invest money in and give attention to the role of oxygen concentrators in LMICs. They will need to buy them, and provide guidelines and policies to encourage their use at lower levels of healthcare. If not, organisations won’t get any traction in selling Oxygen-as-a-Service in the healthcare settings where they are needed most.
Specifically we’d like to see as a result of our evidence:
global and national changes to oxygen policy and investment
the use of appropriate oxygen solutions in context - including where applicable, concentrators and Oxygen-as-a-Service.
To achieve this we will:
Use our learning to inform appropriate changes to global policy and investment
Engage stakeholders in the countries where we work, to understand key barriers to uptake, evidence needed, including their integration into policy and national budget lines (as appropriate, informed by evidence)
Explore bridge funding mechanisms (where appropriate) to reduce the risks to governments of scaling new products and services.
Ensuring the uptake of evidence at national and global levels
Key Resources and insights from the CoLab network
Oxygen CoLab Evidence Framework: showing the evidence we think is needed to achieve our goals, that we are pleased to share as a global good. We’d love to know what you think, and whether our evidence collection can complement yours. In time, we will continue to add evidence as it becomes available
Oxygen System Stories: a series of stories from an incredible network of funders, innovators, advocates, policy makers, researchers and human beings accelerating access to oxygen in low-resource settings.
LATEST NEWS
